Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

New England Journal of Medicine

Volumn 343, Issue 4, 2000, Pages 230-238

  Shapiro, A M James ^a,b   Lakey, Jonathan R T ^a   Ryan, Edmond A ^a   Korbutt, Gregory S ^a   Toth, Ellen ^a   Warnock, Garth L ^a   Kneteman, Norman M ^a   Rajotte, Ray V ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; IMIPENEM; INTERLEUKIN 2 RECEPTOR ANTIBODY; PENTAMIDINE; RAPAMYCIN; TACROLIMUS; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALIC INCLUSION BODY DISEASE; GLUCOSE HOMEOSTASIS; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MIDDLE AGED; SIROLIMUS; TACROLIMUS; TRANSPLANTATION CONDITIONING;

EID: 0034721255     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200007273430401     Document Type: Article

References (40)

1. Brendel M, Hering B, Schulz A, Bretzel R. International Islet Tranplant Registry report. Giessen, Germany: University of Giessen, 1999:1-20.
2. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997;46:1120-3.
3. Lakey JR, Warnock GL, Shapiro AM, et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999;8:285-92.
4. Zeng YC, Ricordi C, Lendoire J, et al. The effect of prednisone on pancreatic islet autografts in dogs. Surgery 1993;113:98-102.
5. Weinand S, Jahr H, Hering BJ, Federlin K, Bretzel RG. Oxygen radical production in human mononuclear blood cells is not suppressed by drugs used in clinical islet transplantation. J Mol Med 1999;77:121-2.
6. Pak CY, Eun HM, McArthur RG, Yoon JW, Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 1988;2:1-4.
7. Numazaki K, Goldman H, Seemayer TA, Wong I, Wainberg MA. Infection by human cytomegalovirus and rubella virus of cultured human fetal islets of Langerhans. In Vivo 1990;4:49-54.
8. Darenkov IA, Marcarelli MA, Basadonna GP, et al. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy. Transplantation 1997;64:848-52.
9. Lakey JR, Warnock GL, Rajotte RV, et al. Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation 1996;61:1047-53.
10. Ricordi C, Lacy PE, Scharp DW. Automated islet isolation from human pancreas. Diabetes 1989;38:Suppl 1:140-2.
11. Brandhorst H, Brandhorst D, Brendel MD, Hering BJ, Bretzel RG. Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant 1998;7:489-95.
12. Rosenberg L, Wang R, Paraskevas S, Maysinger D. Structural and functional changes resulting from islet isolation lead to islet cell death. Surgery 1999;126:393-8.
13. Vargas F, Vives-Pi M, Somoza N, et al. Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation. Transplantation 1998;65:722-7.
14. Ricordi C, Gray DW, Hering BJ, et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990;27:185-95.
15. Korbutt GS, Elliott JF, Ao Z, Smith DK, Warnock GL, Rajotte RV. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 1996;97.2119-29.
16. Shapiro AM, Lakey JR, Rajotte RV, et al. Portal vein thrombosis after transplantation or partially purified pancreatic islets in a combined human liver/islet allograft. Transplantation 1995;59:1060-3.
17. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-55.
18. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2.
19. Verge CF, Stenger D, Bonifacio E, et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 1998;47:1857-66.
20. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
21. Hering B, Ricordi C. Islet transplantation for patients with type 1 diabetes. Graft 1999;2:12-27.
22. Kaufman DB, Gores PF, Field MJ, et al. Effect of 15-deoxyspergualin on immediate function and long-term survival of tranplanted islets in murine recipients of a marginal islet mass. Diabetes 1994;43:778-83.
23. Bennet W, Sundberg B, Groth CG, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 1999;48:1907-14.
24. Kenyon NS, Ranuncoli A, Masetti M, Chatzipetrou M, Ricordi C. Islet transplantation: present and future perspectives. Diabetes Metab Rev 1998;14:303-13.
25. Shapiro AM, Hao E, Lakey JR, Elliott JF, Rajotte RV, Kneteman NM. Development of diagnostic markers for islet allograft rejection. Transplant Proc 1998;30:647.
26. Drachenberg CB, Klassen DK, Weir MR, et al. Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999;68: 396-402.
27. Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22,989), a new anti-fungal antibiotic. II. Fermentation, isolation and characterization. Antibiot (Tokyo) 1975;28:727-32.
28. Kahan BD. Podbielski J, Napoli KL, Katz SM, Meier-Kriesche HU, Van Buren CT. Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation. Transplantation 1998;66:1040-6.
29. Groth CG, Backman L, Morales JM, et al. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Transplantation 1999;67:1036-42.
30. Yakimets WJ, Lakey JR, Yatscoff RW, et al. Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses: rapamycin efficacy is blood level related. Transplantation 1993;56:1293-8.
31. Kneteman NM, Lakey JR, Wagner T, Finegood D. The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. Transplantation 1996;61:1206-10.
32. Kahan BD. Cyclosporin A, FK506, rapamycin: the use of a quantitative analytic tool to discriminate immunosuppressive drug interactions. J Am Soc Nephrol 1992;2:Suppl:S222-S227.
33. Chen H, Qi S, Xu D, et al. Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse. Transplant Proc 1998;30:2579-81.
34. Vu MD, Qi S, Xu D, et al. Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. Transplantation 1997;64: 1853-6.
35. McAlister VC, Gao Z, Peltekian K, Domingues J, Mahalati K, MacDonald AS. Sirolimus-tacrolimus combination immunosuppression. Lancet 2000;355:376-7.
36. Vincenti F, Kirkman R, Light S, et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med 1998;338:161-5.
37. Halloran PF. T-cell activation pathways: a transplantation perspective. Transplant Proc 1999;31:769-71.
38. Bretzel RG, Brandhorst D, Brandhorst H, et al. Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management. J Mol Med 1999;77:140-3.
39. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997;46:271-86.
40. Bartlett ST, Schweitzer EJ, Johnson LB, et al. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation: a prospective trial of tacrolimus immunosuppression with percutaneous biopsy. Ann Surg 1996;224:440-52.